BERLIN, Aug. 7, 2017 /PRNewswire/ -- Bruker today announced that it has acquired XGLab S.r.l., a company that develops and manufactures analytical instruments for applications in the field of X-Ray spectrometry and imaging, as well as advanced electronics for X-Ray and Gamma radiation detection. Financial details of the transaction were not disclosed.

Located in Milan, Italy, XGLab was established in 2009 as spin-off of the Politecnico di Milano, one of Italy's leading technical universities. The company originates from a research group with a history of innovation in the field of nuclear electronics and radiation detectors. XGLab introduced its portable small-spot X-Ray Fluorescence (XRF) analyzer ELIO in 2012, followed by the macro-XRF scanner CRONO in 2014. Both instruments, as well as the recently introduced combined XRF and Raman analyzer, XRAMAN, serve the need for in-situ characterization in art and conservation science, forensics, material science and process control. XGLab also supplies the CUBE, a highly innovative and unique preamplifier based on CMOS technology for various X-Ray and Gamma Ray detectors.

Thomas Schuelein, President of the Bruker Nano Analytics Division, stated: "We are very pleased to welcome the XGLab team to our division. Their instruments perfectly fit into our portfolio of handheld and mobile spectrometers for elemental analysis and imaging, and will allow us to serve our customers in many application fields even better, particularly in art & conservation and materials research. In addition, XGLab's expertise in detector electronics and customized spectrometers will enhance our technology base and help us drive further innovation in X-Ray detection and analysis."

Tommaso Frizzi, Ph.D., co-founder and CEO of XGLab, commented: "XGLab's team is proud to become part of Bruker. This is the logical next step of what we started in 2009, when we decided to transfer the results of our academic research to industrial products and services. We believe that Bruker is a very good environment for XGLab to continue to innovate, and that XGLab's and Bruker's customers will benefit from our synergies."

XGLab will continue to operate under its current name and management, and is also looking forward to expand its read-out and signal processing OEM business with existing and additional partners.

About Bruker Corporation (NASDAQ: BRKR)

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.